Experimental Prediction of the Evolution of Cefepime Resistance From the CMY-2 AmpC ß-Lactamase

Corresponding author: Barry G. Hall, Hutchison Hall, River Campus, University of Rochester, Rochester, NY 14627-0211., drbh{at}mail.rochester.edu (E-mail)

Communicating editor: H. OCHMAN

Understanding of the evolutionary histories of many genes has not yet allowed us to predict the evolutionary potential of those genes. Intuition suggests that current biochemical activity of gene products should be a good predictor of the potential to evolve related activities; however, we have little evidence to support that intuition. Here we use our in vitro evolution method to evaluate biochemical activity as a predictor of future evolutionary potential. Neither the class C Citrobacter freundii CMY-2 AmpC ß-lactamase nor the class A TEM-1 ß-lactamase confer resistance to the ß-lactam antibiotic cefepime, nor do any of the naturally occurring alleles descended from them. However, the CMY-2 AmpC enzyme and some alleles descended from TEM-1 confer high-level resistance to the structurally similar ceftazidime. On the basis of the comparison of TEM-1 and CMY-2, we asked whether biochemical activity is a good predictor of the evolutionary potential of an enzyme. If it is, then CMY-2 should be more able than the TEMs to evolve the ability to confer higher levels of cefepime resistance. Although we generated CMY-2 evolvants that conferred increased cefepime resistance, we did not recover any CMY-2 evolvants that conferred resistance levels as high as the best cefepime-resistant TEM alleles.

This article has been cited by other articles:

				G. A. Jacoby AmpC {beta}-Lactamases Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182. [Abstract] [Full Text] [PDF]

				J.-i. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, N. Shibata, K. Kimura, Y. Ike, and Y. Arakawa Horizontal Transfer of blaCMY-Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19 Antimicrob. Agents Chemother., February 1, 2006; 50(2): 534 - 541. [Abstract] [Full Text] [PDF]

				C. Pichardo, J. M. Rodriguez-Martinez, M. E. Pachon-Ibanez, C. Conejo, J. Ibanez-Martinez, L. Martinez-Martinez, J. Pachon, and A. Pascual Efficacy of Cefepime and Imipenem in Experimental Murine Pneumonia Caused by Porin-Deficient Klebsiella pneumoniae Producing CMY-2 {beta}-Lactamase Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3311 - 3316. [Abstract] [Full Text] [PDF]

				K. J. Welsh, M. Barlow, F. C. Tenover, J. W. Biddle, J. K. Rasheed, L. A. Clark, and J. E. McGowan Jr. Experimental Prediction of the Evolution of Ceftazidime Resistance in the CTX-M-2 Extended-Spectrum Beta-Lactamase Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1242 - 1244. [Abstract] [Full Text] [PDF]

				H. Mammeri, H. Nazic, T. Naas, L. Poirel, S. Leotard, and P. Nordmann AmpC {beta}-Lactamase in an Escherichia coli Clinical Isolate Confers Resistance to Expanded-Spectrum Cephalosporins Antimicrob. Agents Chemother., October 1, 2004; 48(10): 4050 - 4053. [Abstract] [Full Text] [PDF]

				M. Nukaga, S. Kumar, K. Nukaga, R. F. Pratt, and J. R. Knox Hydrolysis of Third-generation Cephalosporins by Class C {beta}-Lactamases: STRUCTURES OF A TRANSITION STATE ANALOG OF CEFOTAXIME IN WILD-TYPE AND EXTENDED SPECTRUM ENZYMES J. Biol. Chem., March 5, 2004; 279(10): 9344 - 9352. [Abstract] [Full Text] [PDF]

				H. Mammeri, L. Poirel, P. Bemer, H. Drugeon, and P. Nordmann Resistance to Cefepime and Cefpirome Due to a 4-Amino-Acid Deletion in the Chromosome-Encoded AmpC {beta}-Lactamase of a Serratia marcescens Clinical Isolate Antimicrob. Agents Chemother., March 1, 2004; 48(3): 716 - 720. [Abstract] [Full Text] [PDF]

				B. G. Hall In Vitro Evolution Predicts that the IMP-1 Metallo-{beta}-Lactamase Does Not Have the Potential To Evolve Increased Activity against Imipenem Antimicrob. Agents Chemother., March 1, 2004; 48(3): 1032 - 1033. [Abstract] [Full Text] [PDF]

				S. J. Salipante, M. Barlow, and B. G. Hall GeneHunter, a Transposon Tool for Identification and Isolation of Cryptic Antibiotic Resistance Genes Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3840 - 3845. [Abstract] [Full Text] [PDF]